叔-丁基 N-[(1S,2S)-2-羟基环戊基]氨基甲酯, 98%

tert-butyl N-[(1S,2S)-2-hydroxycyclopentyl]carbamate

(R)-3,3'-双(三苯基硅基)-5,5',6,6',7,7',8,8'-八氢联萘酚膦酸酯, ≥99%,99.9%e.e.

(11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis(triphenylsilyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(2S,3S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2-异丙基-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯, 98%

(2S,3S)-3-(tert-Butyl)-4-(2,6-dimethoxyphenyl)-2-isopropyl-2,3-dihydrobenzo[d][1,3]oxaphosphole

5-溴-2-甲氧基烟酸乙酯

Ethyl 5-bromo-2-methoxynicotinate

99%

(R)-3,3'-双(2,4,6-三异丙基苯基)-1,1'-联萘酚, ≥99%,99.9%e.e.

(R)-3,3'-Bis(2,4,6-triisopropylphenyl)-1,1'-bi-2-naphthol

鸢尾酮

technical, mixture of isomers (mainly the α-isomer), ≥90% (GC)

工业级, 异构体的混合物（主要是α-异构...

(2S,3S)-(+)-2,3-丁二醇, 97 %

(2S,3S)-2,3-Butanediol

6-氯-5-(三氟甲基)吡啶甲酸甲酯, 98%

Methyl 6-chloro-5-(trifluoromethyl)picolinate

4-氧-L-脯氨酸氢溴酸盐, ≥98%

(S)-4-oxopyrrolidine-2-carboxylicacidhydrobromide

Boc-D-丝氨醇(苄氧基), 98%

Boc-D-Serinol(Bzl)

(R)-3,3'-双(2,4,6-三甲基苯基)-1,1'-联萘酚膦酸酯, ≥99%,99.9%e.e.

(11bR)-4-Hydroxy-2,6-bis(2,4,6-trimethylphenyl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(S)-甲基环氧乙烷-2-羧酸酯, 99%

(S)-Methyl oxirane-2-carboxylate

(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, ≥99%,99.9%e.e.

(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

2,2'-双((4S)- 4 -苄基- 2 -恶唑啉), 99%，ee99.9%

2,2'-BIS[(4S)-4-BENZYL-2-OXAZOLINE]

(R)-3,3'-双(2,4,6-三甲基苯基)-5,5',6,6',7,7',8,8'-八氢-1,1'-联萘酚磷酸酯, ≥99%,99.9%e.e.

(11bR)​-8,​9,​10,​11,​12,​13,​14,​15-​Octahydro-​4-​hydroxy-​2,​6-​bis(2,​4,​6-​trimethylphenyl)​-4-​oxide-dinaphtho[2,​1-​d:1',​2'-​f]​[1,​3,​2]​dioxaphosphepin

(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, ≥99%,99.9%e.e.

(11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis[2,4,6-tris(1-methylethyl)phenyl]-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(R)-2,2'-二苯基-3,3'-(4-联菲酚), 98%

(R)-VAPOL

(R)-3,3'-双(2-萘基)-1,1'-联萘酚膦酸酯, ≥99%,99.9%e.e.

(11bR)-4-Hydroxy-2,6-di-2-naphthalenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

(R)-(-)-苯基丁二酸, ≥96%,sum of enantiomers

(R)-(-)-Phenylsuccinic acid

(11bS)-N,N,2,6-Tetramethyl-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, ≥99%,≥99.9% e.e.

(11bS)-N,N,2,6-Tetramethyl-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine